Is amphotericin B active against dermatophytes and Scopulariopsis brevicaulis?;¿Es activa la amfotericina B frente a hongos dermatófitos y Scopulariopsis brevicaulis?

Revista Espanola de Quimioterapia

Volumn 17, Issue 3, 2004, Pages 244-249

  Carrillo Munoz A J ^a   Santos, P ^b   Del Valle, O ^c   Casals, J B ^d   Quindos G ^e  

^a Associacio Catalana d'Intelligencia Artificial   (Spain)

^b Hosp de Pediatrie J G Garrahan   (Argentina)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d Rosco Diagnostica   (Denmark)

^e UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Amphotericin B; Clotrimazole; Dermatophytes; Griseofulvin; Ketoconazole; Terbinafine

Indexed keywords

AMPHOTERICIN B; AMPICILLIN; CLOTRIMAZOLE; GRISEOFULVIN; KETOCONAZOLE; TERBINAFINE; ANTIFUNGAL AGENT;

AGAR GEL DIFFUSION; ANTIFUNGAL ACTIVITY; ARTICLE; CLINICAL PROTOCOL; DERMATOPHYTE; DRUG SENSITIVITY; NONHUMAN; SCOPULARIOPSIS BREVICAULIS; ARTHRODERMA; ASCOMYCETES; DRUG EFFECT; MICROBIOLOGICAL EXAMINATION;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ARTHRODERMATACEAE; ASCOMYCOTA; MICROBIAL SENSITIVITY TESTS;

EID: 9744232938     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Lecha-Carralero, M. Onicomicosis. Aula Médica. Madrid 1995.
2. Boisseau-Garsaud, A.M., Desbois, N., Guillermin, M.L., Ossondo, M., Gueho, E., Cales-Quist, D. Onychomycosis due to Exophiala jeanselmei. Dermatol 2002; 204: 150-152.
3. Filipello-Marchisio. V. Keratinophilic fungi: Their role in nature and degradation of keratinic substrates. En: Kushawa, R.K.S., Guarro, J. (Eds.). Biology of dermatophytes and other keratinophilic fungi. Bilbao 2000; 86-92.
4. Nucci, M., Anaissie, E. Cutaneous infection by Fusariam species in healthy and immunocompromised hosts: Implications for diagnosis and management. Clin Infect Dis 2002; 35: 909-920.
5. Virgili, A., Zampino, M.R., Mantovani, L. Fungal skin infections in organ transplant recipients. Am J Clin Dermatol 2002; 3: 19-35.
6. Ellis, D.H. Clinical Mycology. The human opportunistic mycoses. Gillingham Printers Pty, Ltd., Underdale, Australia 1994.
7. Bell-Syer, S.E.M., Hart, R., Crawford, F. y cols. A systematic review of oral treatments for fungal infections of skin and feet. J Dermatol Treat 2001; 12: 69-74.
8. Del Palacio, A., Garau, M., González-Escalada, A., Calvo, M.T. Trends in the treatment of dermatophytoses. En: Kushwaha, R.K.S., Guarro, J. (Eds.). Biology of dermatophtytes and other keratinophilic fungi. Rev Iberoam Micol 2000; 148-158.
9. Carrillo-Muñoz, A.J., Pemán, J, Gobernado, M. Nuevos antifúngicos. Rev Esp Quimioterap 1999; 12: 181-204.
10. Carrillo-Muñoz, A.J., Brió, S., Quindós, G. Una nueva generación de fármacos antifúngicos. Rev Iberoam Micol 2001; 18: 4-7.
11. Carrillo-Muñoz. A.J., Quindós. G., López-Ribot, J.L. Current developments in antifungal agents: Present and future. Curr Med Chem Anti-Infect Agents 2004; 3: in press.
12. Carrillo-Muñoz, A.J. Antifúngicos antibioticos de usa tópico. Act Dermatol 1996; 387.
13. Alou-Cervera, L., Maestre, J.R., Moreno-Úbeda, J. y Grupo para el Estudio del Consume de Antimicrobianos en España. Use of topical antifungal agents in Spain. Rev Esp Quimioterap 2002; 14: 340-344.
14. Fernandez-Torres, B., Vázquez-Veiga, H., Llovo, X., Pereiro, Jr. M., Guarro, J. In vitro susceptibility to itraconazole, clotrimazole, ketoconazole and terbinafine of 100 isolates of Tricliophyton rubrum. Chemother 2000; 46: 90: 394.
15. Fernández-Torres, B., Carrillo, A.J., Martín, E. y cols. In vitro activities of 10 antifungal drugs against 508 dennatophyte strains. Antimicrob Agents Chemother 2000; 45: 2524-2528.
16. Fernández-Torres, B., Carrillo-Muñoz, A.J., Ortoneda, M., Pujol, I., Pastor, J., Guarro, J. Interlaboratory evaluation of the E-test® for antifungal susceptibility testing. Med Mycol 2003; 41: 125-130.
17. Cuétara, M. Procesamiento de las maestros superficiales. En: Pemán, J., Martín-Mazuelos. E., Rubio-Calvo, M.C. (Eds.). Guía práctica de identificación y diagnóstico en Micología Clínica. Rev Iberoam Micol 2001; 4.1-5.12.
18. Cabañes, F.J. Identificación de hongos dermatofitos. En: Pemán, J., Martín-Maznelos. E., Rubio-Calvo, M.C. (Eds.). Guía práctica de identificación y diagnóstico en micología clínica. Rev Iberoam Micol 2001; 12.1-12.11.
19. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard, M38-A. National Committee for Laboratory Standards, Wayne, Pa, USA 2000.
20. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. M27-A2 Approved Standard-Second Edition. National Committee for Laboratory Standards, Wayne, Pa, USA 2002.
21. Carrillo-Muñoz, AJ. Contribución a la estandarización de las pruebas de sensibilidad in vitro a los antifúngicos. Universitat de Barcelona 1994.
22. Rosco. User's guide Neo-Sensitabs®, 16th ed. 2003.
23. Carrillo-Muñoz, A.J., Fernández-Torres, B., Cárdenes, D.C., Guarro, J. In vitro activity of senaconazole against dermatophyte moulds isolates with reduced fluconazole susceptibility. Chemother 2003; 49: 248-251.
24. Carrillo-Muñoz, A.J., Fernández-Torres, B., Guarro, J. In vitro activity of senaconazole against 309 strais of dermatothyte moulds. J Chemother 2003; 15: 555-557.
25. Cantón, E., Martín-Mazuelos, E., Espinel-Ingroff, A. Otros métodos para el estudio de sensibilidad a los antifúngicos. En: Pemán, J., Martín-Mazuelos, E., Rubio-Calvo, M.C. (Eds.). Guía práctica de identificación y diagnóstico en micología clínica. Rev Iberoam Micol 2001; 16.1-16.9.
26. LaRocco, M.T., Burgert, S.J. Fungal infections in the transplant recipient and laboratory methods for diagnosis. Rev Iberoam Micol 1997; 14: 143-146.
27. Odds, F.C. Personal opinion: Can antifungal sensitivity tests predict clinical treatment outcomes? Rev Iberoam Micol 1997; 14: 83-84.
28. Odds, F.C. Should resistance to azole antifungals in vitro be interpreted as predicting clinical non-response? Drug Resistance Updates 1998; 1: 11-15.
29. Carrillo-Munoz, A.J. Multicenter evaluation of the reproducibility of Neo-Sensitabs antifungal sensitivity testing. Rev Iberoam Micol 1994; 11: 56.
30. Pemán, J., Cantón-Lacasa, E. Las pruebas de sensibilidad antifúngica en un laboratorio de microbiología clínica. Rev Esp Quimioterap 1996; 9: 17-20.
31. Rex, J.H., Pfaller, M.A., Rinaldi, M.G., Polak, A., Galgiani, J.N. Antifungal susceptibility testing. Clin Microbiol Rev 1993; 6: 367-381.
32. Carrillo-Muñoz, A.J., Brió, S., Alonso, R., del Valle, O., Santos, P., Quindos, G. Ciclopiroxolamine: In vitro antifungal activity against clinical yeasts isolates. Int J Antimicrob Agents 2002; 20: 375-379.
33. Casals, J.B. Tablet sensitivity testing of pathogenic fungi. J Clin Path 1979; 32: 719-722.
34. Casals, J.B., Pringler, N. Sensitivity testing of yeast against ketoconazole, itraconazole and fluconazole by an agar diffusion method. Scand Meet Bact, Gothenburg, May 1989.
35. Ceballos-Salobreña, A., Gaitán-Cepeda, L.A., Orihuela-Cañada, F., Olea-Barrionuevo, D., Ceballos-García, L., Quindós, G. In vitro antifungal resistance in Candida albicans from HIV-patients with and without oral candidosis. Rev Iberoam Micol 1999; 16: 194-197.
36. Quindós, G., Abarca, L., Carrillo-Muñoz, A.J. y cols. Multicenter survey of in vitro antifungal resistance in yeasts of medical importance isolated from Spanish patients. Rev Iberoam Micol 1996; 16: 97-100.
37. Sandven, P. Detection of fluconazole resistant Candida strains by a disc diffusion screening test. J Clin Microbiol 1999; 37: 3856-3859.
38. Carrillo-Muñoz, A.J., Abarca, L., Quindós, G. y cols. Evaluation of an agar diffusion method for in vitro antifungal susceptibility testing. Rev Esp Quimioterap 1995; 8: 221-228.
39. Cabanes, F.J., Abarca, L., Bragulat, M., Braguera, T. Sensitivity of some strains of the genus Epidermophyton to different antifungal agents. Mycopathol 1989; 105: 153-156.